ADRA1D gene

Known as: ADRA1D, ADRA1A, FORMERLY, adrenoceptor alpha 1D 
 

Topic mentions per year

Topic mentions per year

1994-2018
012319942018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Vascular smooth muscle cell (VSMC) accumulation and hypertrophy are common in vascular disorders, and inflammation has a crucial… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2016
2016
The α1D-adrenergic receptor (ADRA1D) is a key regulator of cardiovascular, prostate, and central nervous system functions. This… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2015
2015
Recent advances in proteomic technology reveal G-protein-coupled receptors (GPCRs) are organized as large, macromolecular protein… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2012
2012
OBJECTIVES Metoclopramide is associated with variable efficacy and side effects when used in the treatment of gastroparesis… (More)
Is this relevant?
2010
2010
Domperidone is a useful alternative to metoclopramide for treatment of gastroparesis due to better tolerability. Effectiveness… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2008
2008
Recent clinical trials have clearly demonstrated that the administration with beta-blockers decreases the mortality in the… (More)
Is this relevant?
2008
2008
Recent clinical trials have clearly demonstrated that the administration with β-blockers decreases the mortality in the patients… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2006
2006
This Perspective focuses on the alpha(1D)-adrenergic receptor (AR), the often neglected sibling of the alpha(1)-AR family. This… (More)
Is this relevant?
2004
2004
A significant proportion of the human genome is contained within haplotype blocks across which pairwise linkage disequilibrium… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?